Last Updated : June 19, 2024
This page is for:
If you represent a patient group or other stakeholder wishing to provide input into research, please visit the Providing Input page on our website that is dedicated to helping you with this.
Please note: Canada’s Drug Agency does not provide medical services or advice to individual patients. If you have a medical problem, please contact a qualified health professional.
What does the evidence say?
We have produced thousands of reports on diverse topics, all of which are freely accessible on the Reports page. You can also complete the following form; however, please keep in mind the following:
This section is for drug manufacturers and tumour groups preparing applications for the review of drugs through our drug reimbursement review process.
Here you can receive advice on early drug development plans from a health technology assessment perspective. This is a fee-for-service consultation offered to drug manufacturers.